Cytotherapy
Издатель: Elsevier · ISSN 1465-3249 · 58 статей
-
Aims and Scope
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s):
-
Editorial Board
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s):
-
Subscription information
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s):
-
Table of Contents
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s):
-
A regulatory gap: addressing visible particle control in cell and gene therapies through a risk-based framework
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Antonio Scatena, Sarah Saietz, Sean Werner, David Stull, Christopher Harrison, Manufacturing Materials Safety & Technology Working Group (formerly the...
-
Comparative analysis of advanced therapy regulatory frameworks in Latin America: perspectives from the ISCT South and Central America Legal and Regulatory Affairs Committee
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Carolina Sepúlveda Márquez, Dominga Berrios Pérez, Bernardita Hurtado de Mendoza Urzúa, Martin Hernan Bonamino, Lilia Carolina León-Moreno, María de...
-
Swissmedic Innovation Office: early regulatory engagement to accelerate ATMP clinical development—regulatory insights and recommendations
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Michel Hauser, Alexander Reichenbach, Andreas Marti, Elise Drouyer, Emile Eichenlaub, François Pinsard, Franziska Isler, Iris Schmitt, Julia Djonova,...
-
Enhanced antitumor efficacy through combined chimeric antigen receptor T cell therapy and CD40 stimulation in syngeneic solid tumor models
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Giulia Golinelli, Ting-Jia Fan, Khatuna Gabunia, Wesley V. Wilson, Charles-Antoine Assenmacher, He N. Xu, Diego Gonzalves, Sofia Castelli, Jordan Reff,...
-
Hypoxia during GPC2-CAR T-cell manufacturing compromises cell expansion and cytotoxic capacity
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Ira Phadke, Ryan A. Hannon, Mary Black, Zoe Schmiechen, Hannah W. Song, Haiyan Lei, Jack F. Shern, Michaela Prochazkova, Jangsuk Oh, Mitchell Ho, Steven...
-
Early detection of chimeric antigen receptor-T-associated neurotoxicity via cytokine monitoring in serum
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Amit Parizat, Onit Alalouf, Danielle Sapir, Nivin Shibli, Ruth Perets, Dvir Aran, Ofrat Beyar Katz, Yoav Shechtman
-
Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting osteosarcomas
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Nadia Mensali, Sandy Joaquina, Constance de Montlaur, Nicholas Paul Casey, Thomas Olsen Nesset, Ola Myklebost, Emmet McCormack, Anna Pasetto, Maria...
-
Pretransplant infection associated with inferior survival after TCRαβ/CD19-depleted haploidentical HSCT in pediatric nonmalignant disorders
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Gal Dadi, Etai Adam, Elad Jacoby, Sarah Malkiel, Daphna Hutt, Nira Varda-Bloom, Amos Toren, Bella Bielorai
-
Multi-site validation and applicability assessment of a practical three-dimensional colony formation assay for detecting malignantly transformed cells
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Kiyoko Bando, Shinji Kusakawa, Hideki Adachi, Mika Yamamoto, Yuka Bando, Rieko Fujiwara, Miki Iwata, Atsushi Kitanaka, Yuki Nishioka, Eiichiro Ogimura,...
-
Evaluation of pluripotent stem cell-derived myeloid line-based chimeric antigen receptor macrophage-like cells identifies limited in vivo persistence
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Yuya Atsumi, Akira Niwa, Yohko Kitagawa, Tatsuro Kumaki, Shigeki Yagyu, Yozo Nakazawa, Megumu K. Saito
-
Integrated T-cell enrichment, static transduction, and expansion in gas-permeable bioreactors for adoptive cell therapy
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Nikolaos Gkitsas-Long, Aidan J. Retherford, Carely Fowler, Dorota D. Klysz, Andrew Scheffler, Dan Fick, Janette Mata Alcazar, Annie K. Brown, Casey...
-
Automating chimeric antigen receptor T-cell manufacturing across distinct platforms delivers similar cell quality, phenotype and function
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Eu Han Lee, Meredith Safford, Terri Staab, Min Sung Park, Mack Ryan, Despina Pleitez, Alex Sargent
-
Phenotype-outcome standards must guide personalized CAR-T manufacturing
Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Carlos Victor Montefusco-Pereira, Howard Lopes Ribeiro Junior
-
Mesenchymal stromal cells for progressive multiple sclerosis: current evidence and translational challenges
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Laure Michel, Lucie Rio, Karin Tarte
-
Cell therapies: are we doing enough to protect patients and address the barriers to patient access?
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Michael Creane, Bambi J. Grilley, Miguel Forte, Fermin Sanchez-Guijo, Christian Jorgensen, Ivan Martin, Laertis Ikonomou, Sowmya Viswanathan
-
Consensus perspectives on quality control and safety strategies for the clinical translation of induced pluripotent stem cell−derived cell therapies
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Vladislav Krupalnik, Shin Kawamata, Joanne Mountford, George Muschler, Hiroto Bando, Wanxing Cui, Xiaokui Zhang, Tenneille E. Ludwig, Lise Munsie, Natacha...
-
Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Susie Long, Veronika Bachanova, Qing Cao, Christen L. Ebens, Troy C. Lund, Margaret L MacMillan, Alex Hoover
-
Semi-automated manufacturing preserves memory-associated and metabolic features of piggyBac CAR-T cells
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Konomi Morita, Megumi Wada, Moe Washizawa, Tomoya Inoue, Hidemi Sato, Akane Miura, Yuko Yaguchi, Fumi Saito, Takafumi Mano, Momona Hirayama, Tsuyoshi...
-
Overcoming the bottleneck: CD3Predict tool to streamline and improve access to chimeric antigen receptor T-cell leukapheresis
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Maeve A O’Reilly, Aman Malhi, Gabriel Naylor-Leyland, Fady Samy, Kathleen PL Cheok, Stuart Ings, Helen Keane, Katarzyna Jalowiec, Eleni-anna Verigou,...
-
Three-dimensional mesenchymal stromal cell spheroids potently suppress neutrophil extracellular trap formation
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Juliana Borges Vieira, Mariana Alves Antunes Almeida, Carla Medeiros da Silva, Marianna Ribeiro Cabral, Renata Trabach Santos, Christina Maeda Takiya,...
-
Building a Clinical-Grade Allogenic Adipose-Derived MSC Therapy for Epidermolysis Bullosa
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Lucie Jureckova, Marie Mlnarikova, Jana Kubatova, Sofiia Lymarenko, Katerina Cerna-Pilatova, Lucie Flajsarova, Jakub Jamarik, Anastasiya Volakhava, Jitka...
-
Trajectory clustering of longitudinal donor chimerism after pediatric hematopoietic stem cell transplantation for non-malignant disorders
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Neta Nevo, Hila Rosenfeld Keidar, Ronit Elhasid
-
Calibrated prediction of CD34+ yield and apheresis product CD34+ concentration for allogeneic donor collection planning
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Hilmi Erdem Gözden, Bedrettin Orhan, Nihan Alkış
-
Large-particle T-cell activation improves manufacturability, reduces phagocytic loss and enhances chimeric antigen receptor-T cell cytotoxic function
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Matic Bartol, Tina Fink, Tina Tragin, Ema Pleško, Roman Jerala, Hana Esih, Aljaž Kravanja, Brina Štante, Valentina Bianco, Luka Fajs, Mojca Jež